series-c-plus
Stage
1
Investors
About
Sensei Bio is a US-based biopharmaceutical company focused on developing drug therapeutics. According to the Catalio Capital portfolio listing it completed an IPO in 2021 and is categorized under drugs.
Explore Sensei Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.